Under the intervention of BEZ235, the growth and invasion activities of HepG2 cells were greatly suppressed, which indicated that suppression of the PI3K/Akt/mTOR pathway could impact the viability of HCC cells, which was consistent with prior research results [21]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.